Treace Medical Concepts, Inc. TMCI
4.28 USD +0.01 (+0.23%)
At closeNov 3, 2026, 4:00 PM EST
4.28 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
4.21 Day range 4.38
1.17 52-week range 6.58
- YTD
- +74.69%
- 1 year
- -35.05%
Financial health
Altman Z-Score
-0.03 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 2
Valuation
P/E -2.6×
FY 2019 5y median -15.7× FY 2025
P/S 0.7×
FY 2019 5y median 4.1× FY 2025
P/B 1.8×
FY 2019 5y median 5.6× FY 2025
P/FCF -5.3×
FY 2019 5y median -16.9× FY 2025
EV/EBITDA -3.7×
FY 2019 5y median -21.4× FY 2025
EV/Sales 0.7×
FY 2019 5y median 4.5× FY 2025
FCF Yield -19.0%
FY 2019 5y median -5.9% FY 2025
Profitability
Gross Margin 79.8%
FY 2019 5y median 80.6% FY 2025
Operating Margin -25.5%
FY 2019 5y median -25.5% FY 2025
Net Margin -27.7%
FY 2019 5y median -26.6% FY 2025
ROE -67.6%
FY 2019 5y median -49.4% FY 2025
ROIC -33.9%
FY 2019 5y median -27.0% FY 2025
ROA -31.0%
FY 2019 5y median -25.7% FY 2025
Growth (YoY)
Revenue 1.6%
FY 2019 FY 2025
Operating Income 2.8%
FY 2019 FY 2025
EPS (diluted) -3.3%
FY 2019 FY 2025
Free Cash Flow 39.5%
FY 2019 FY 2025
Financial Health
Current Ratio 4.3×
FY 2019 5y median 4.4× FY 2025
Quick Ratio 3.1×
FY 2019 5y median 3.8× FY 2025
Debt / Equity 0.2×
FY 2019 5y median 0.5× FY 2025
Net Debt / EBITDA -0.1×
FY 2019 5y median -1.4× FY 2025
Interest Coverage -10.2×
FY 2019 5y median -10.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31